Fatty acid oxidation is an adaptive survival pathway induced in prostate tumors by HSP90 inhibition by Nassar, ZD, Mah, CY, Centenera, MM, Irani, S, Sadowski, MC, Scott, JS, Nguyen, EV, Nagarajan, SR, Moldovan M, Lynn, DJ, Daly, RJ, Hoy, AJ, Butler, LM

Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer by Mah, CY, Nguyen, ADT, Niijima, T, Helm, M, Dehairs, J, Ryan, FJ, Ryan, N, Quek, L, Hoy, AJ, Don, AS, Mills, IG, Swinnen, JV, Lynn, DJ, Nassar, ZD, Butler, LM

ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer by Centenera, MM, Scott, JS, Machiels, J, Nassar, ZD, Miller, DC, Zininos, I, Dehairs, J, Burvenich, IJG, Zadra, G, Chetta, P, Bango, C, Evergren, E, Ryan, NK, Gillis, JL, Mah, CY, Tieu, T, Hanson, AR, Carelli, R, Bloch, K, Panagopoulos, V, Waelkens, E, Derua, R, Williams, ED, Evdokioou, A, Cifuentes-Rius, A, Voelcker, NH, Mills, IG, Tilley, WD, Scott, AM, Loda, M, Selth, LA, Swinnen, JV, Butler, LM